603717 天域生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.647-22.961-18.440-52.666-24.726
总资产报酬率 ROA (%)-0.365-3.500-3.310-13.779-9.241
投入资产回报率 ROIC (%)-0.595-5.550-4.988-20.336-13.355

边际利润分析
销售毛利率 (%)6.524-0.12510.833-34.41811.326
营业利润率 (%)-4.314-14.045-11.188-84.931-34.186
息税前利润/营业总收入 (%)3.078-12.013-9.631-83.382-31.980
净利润/营业总收入 (%)-4.307-14.060-10.835-84.404-28.415

收益指标分析
经营活动净收益/利润总额(%)293.396114.58353.41262.3899.504
价值变动净收益/利润总额(%)-296.147-4.6960.2456.237-0.582
营业外收支净额/利润总额(%)2.724-5.899-2.8831.583-1.968

偿债能力分析
流动比率 (X)0.8860.8501.0791.3141.693
速动比率 (X)0.6880.6800.9131.1861.481
资产负债率 (%)79.51079.48177.96274.50559.130
带息债务/全部投入资本 (%)57.63260.34255.96850.30942.066
股东权益/带息债务 (%)37.23039.04944.09758.272112.619
股东权益/负债合计 (%)16.76517.93520.69626.48054.637
利息保障倍数 (X)0.410-9.616-7.744-28.604-20.685

营运能力分析
应收账款周转天数 (天)162.352171.278173.209229.198198.575
存货周转天数 (天)145.459111.11796.56279.76774.263